Aptamer Group
York, United Kingdom aptamergroup.com
From their website, Nov 2026
Work here? Claim this listing
About
Aptamer Group develops custom Optimer® aptamer binders and related assay solutions for life sciences customers. It works with global pharmaceutical, diagnostic, biotech, and bioprocessing organizations from its York, UK site.
Services
Custom Optimer® development
Custom solutions using the Optimer® affinity platform to solve targeting challenges from early discovery through clinical development.
Biomarker discovery service
Discovery and validation of novel biomarkers by comparing healthy and diseased cell phenotypes, including cell-surface and intracellular protein targets.
Custom development workflow
A staged workflow covering consultation, in vitro selection, clonal analysis and Optimer development, assay development, and supply.
Bioprocessing solutions
Optimer-based affinity purification and quality control reagents for bioprocessing and manufacturing workflows.
Assay development
Characterisation, validation, and development of application-ready assays for custom Optimer binders.
Custom bioanalytical reagents
Development of Optimer reagents as antibody alternatives for detection and quantification assays in plasma, serum, or tissue.
Optimer binders to license
Optimer binders available to trial or license with custom modifications for platform integration.
Optimer® binder licensing
Provides Optimer® binders available to trial or license with custom modifications for platform integration.
Therapeutics development
Develops Optimer® binders for therapeutic inhibitors, modulators, and targeted delivery applications.
Diagnostics and reagents
Develops Optimer® binders for diagnostic and research assays.
Biomarker discovery
Identifies biomarkers from healthy versus disease-state cells using Optimer-based phenotypic discovery.
- Turnaround
- From weeks to months
- What to send
- Targets can be cells, proteins and peptides, or small molecules. · Comparisons may use different tissues, liquid biopsies, or healthy vs. diseased cell models.
Capabilities
- Assays and studies
- ELISA · SPR · BLI · Flow cytometry · FACS · Cell-based inhibition/activation assays · Affinity chromatography · WB · Fluorescence microscopy · IHC · Luminex · Enzyme activity assays
4 more
Immunocytochemistry · Cell viability and proliferation assays · Apoptosis and internalisation assays · Biolayer interferometry - Scale and capacity
- Manufacturing scale
- Therapeutic areas
- Therapeutics · Diagnostics · Bioprocessing · Drug delivery · Biomarker discovery · Oncology · Neurology · Metabolism · Radiopharmaceuticals · Alzheimer's disease
Instruments and platforms
- Octet RH16
- Biolayer interferometry
- Mass spectrometry
Modalities and species
- Modalities
- Small molecule · Antibody · Peptide · Oligonucleotide
- Species and models
- Cells · Primary fibrotic liver cells · Primary fibrotic hepatic stellate cells · Healthy cells · Diseased cells · Cancer cells · Healthy vs diseased cell models · Cancer vs healthy · Resistant vs sensitive · Activated vs quiescent · Liquid biopsies
Industries served
- Pharmaceutical
- Diagnostic
- Biotech
- Bioprocessing
- Consumer cosmetic
Company
- Quality
- ICH M10 (bioanalytical method validation guideline naming aptamers among binding reagents)
Locations
- Address
- 29 Wellington Street Leeds LS1 4DL All enquiries concerning your shareholding should be di
- Sites
- York, UK
- Serves
- global
Contacts
- General enquiry
- info@aptamergroup.com on their site
- Phone
- +44 (0) 1904217404
Public records
- Parent company
- APTAMER GROUP PLC · GB GLEIF
Similar labs
Work here? Claim this listing